Generic prescription drugs usually save consumers money because they are the same as the name brand, but the patent has ...
Boehringer Ingelheim, IP Group, the UK Respiratory Gene Therapy Consortium (GTC) 1 and OXB, 1 today announce the start of LENTICLAIR TM 1, a Phase I/II trial of BI 3720931, a novel, first-in-class, ...
We appreciate the constructive dialogue that we've had with our shareholders and want to thank them for their feedback and support,” said Alvaro Garcia-Tunon, Chair of the Board. “The outcome of today ...
The environmental testing market is estimated at USD 7.43 billion in 2025 and is projected to reach USD 9.32 billion by 2030, at a CAGR of 4.6% ...
Rights Aug 02, 2023 Aug 02, 2023 Feb 08, 2023 Rights ratio: 5 share for every 46 held at a price of Rs 81.0 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results